Data from: Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin

负责人：

关键词：

Nazartinib;EGF816;human serum albumin;fluorescence quenching

DOI：

doi:10.5061/dryad.05c6v93

摘要：

of therapeutics.?Nazartinib?(EGF 816; NAZ) is a new anti-cancer candidate proposed as a third-generation epidermal growth factor receptor (EGFR)